Speaker: Evan Lewis MD FRCPC

Dr. Evan Cole Lewis is a Neurologist and Clinical Neurophysiologist with expertise in pediatric neurology and epilepsy. He is an Assistant Professor with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto.

Dr. Lewis is the founder & medical director of the Neurology Centre of Toronto (NCT), Chief Medical Advisor for the Jamaican Medical Cannabis Corporation and VP Psychedelic Neurology at Numinus – a Canadian company focused on research and therapeutics with psychedelic medicines. Dr. Lewis has clinical experience and special interest with psychedelic medicine and medical cannabis in the treatment of neurological conditions in adults and children. He is a strong advocate for the use of virtual medicine to reach the underserved areas of Ontario, Canada.

Dr. Lewis focuses on indications, treatment and novel approaches of psychedelic medicines. He has clinical experience counselling patients with underlying neurologic conditions who have utilized psychedelics such as psilocybin, MDMA and ketamine. His clinic now offers ketamine-assisted therapy to treat functional neurological disorders, persistent post-concussive symptoms and co-morbid conditions that arise from neurologic diagnoses.

Dr. Lewis attained his MD from the University of Ottawa and trained as a Pediatric Neurologist at the Children’s Hospital of Eastern Ontario (CHEO). He completed fellowships in both clinical neurophysiology and epilepsy at Nicklaus Children’s Hospital (formerly known as Miami Children’s Hospital) and the Hospital for Sick Children. Dr. Lewis held staff positions at SickKids and Holland Bloorview Kids Rehabilitation Hospital between 2016 and 2018. Dr. Lewis is a Fellow of the Royal College of Physicians of Canada and was the Tariff Chair of the Neurology Section for the Ontario Medical Association from 2017 - 2019.